Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection.

Glasser SW, Witt TL, Senft AP, Baatz JE, Folger D, Maxfield MD, Akinbi HT, Newton DA, Prows DR, Korfhagen TR.

Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L64-72. doi: 10.1152/ajplung.90640.2008. Epub 2009 Mar 20.

2.

Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury.

Glasser SW, Senft AP, Maxfield MD, Ruetschilling TL, Baatz JE, Page K, Korfhagen TR.

Respir Res. 2013 Feb 12;14:19. doi: 10.1186/1465-9921-14-19.

4.
5.

Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice.

Glasser SW, Maxfield MD, Ruetschilling TL, Akinbi HT, Baatz JE, Kitzmiller JA, Page K, Xu Y, Bao EL, Korfhagen TR.

Am J Respir Cell Mol Biol. 2013 Nov;49(5):845-54. doi: 10.1165/rcmb.2012-0374OC.

7.

Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.

Li W, Shen HH.

Chin Med J (Engl). 2007 Jan 5;120(1):5-11.

PMID:
17254480
9.
10.

Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.

Atochina EN, Beck JM, Scanlon ST, Preston AM, Beers MF.

J Lab Clin Med. 2001 Jun;137(6):429-39.

PMID:
11385364
11.

Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.

Cho JY, Miller M, Baek KJ, Castaneda D, Nayar J, Roman M, Raz E, Broide DH.

J Allergy Clin Immunol. 2001 Nov;108(5):697-702.

PMID:
11692091
12.

Host transcription profiles upon primary respiratory syncytial virus infection.

Janssen R, Pennings J, Hodemaekers H, Buisman A, van Oosten M, de Rond L, Ozt├╝rk K, Dormans J, Kimman T, Hoebee B.

J Virol. 2007 Jun;81(11):5958-67. Epub 2007 Mar 21.

13.

Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.

Stark JM, Khan AM, Chiappetta CL, Xue H, Alcorn JL, Colasurdo GN.

J Infect Dis. 2005 Feb 1;191(3):387-95. Epub 2004 Dec 22.

PMID:
15633098
14.

[Effects of respiratory syncytial virus infection on T-helper cytokines expression in Balb/c mice sensitized with ovalbumin].

Zou Y, Xu J, Zhong N.

Zhonghua Jie He He Hu Xi Za Zhi. 2002 Aug;25(8):470-4. Chinese.

PMID:
12425832
15.

Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.

Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW.

J Virol. 2005 Mar;79(6):3350-7.

16.

Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.

Stark JM, Stark MA, Colasurdo GN, LeVine AM.

J Med Virol. 2006 Jun;78(6):829-38.

PMID:
16628585
17.

[Toll-like receptor 4 expression and function of respiratory syncytial virus-infected airway epithelial cells].

Xie XH, Liu EM, Yang XQ, Law HK, Li X, Wang LJ, Liu W, Xu WF.

Zhonghua Jie He He Hu Xi Za Zhi. 2008 Mar;31(3):213-7. Chinese.

PMID:
18785522
19.

Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T.

J Clin Invest. 1999 Apr;103(7):1015-21.

20.

Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.

Barends M, Van Oosten M, De Rond CG, Dormans JA, Osterhaus AD, Neijens HJ, Kimman TG.

J Infect Dis. 2004 May 15;189(10):1866-72. Epub 2004 Apr 27.

PMID:
15122523

Supplemental Content

Support Center